Geode Capital Management
TMO icon

Geode Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Geode Capital Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.11B Buy
8,407,891
+211,414
+3% +$115M 0.26% 59
2025
Q4 		$4.73B Buy
8,196,477
+26,425
+0.3% +$14.9M 0.29% 51
2025
Q3 		$3.94B Buy
8,170,052
+55,265
+0.7% +$25.7M 0.25% 60
2025
Q2 		$3.27B Sell
8,114,787
-12,399
-0.2% -$5.18M 0.23% 71
2025
Q1 		$4.03B Buy
8,127,186
+269,801
+3% +$146M 0.32% 46
2024
Q4 		$4.08B Buy
7,857,385
+197,442
+3% +$109M 0.32% 43
2024
Q3 		$4.72B Buy
7,659,943
+127,564
+2% +$75.5M 0.38% 36
2024
Q2 		$4.15B Buy
7,532,379
+37,188
+0.5% +$21.3M 0.36% 38
2024
Q1 		$4.34B Buy
7,495,191
+203,298
+3% +$114M 0.4% 36
2023
Q4 		$3.86B Buy
7,291,893
+173,554
+2% +$84M 0.4% 37
2023
Q3 		$3.59B Buy
7,118,339
+139,470
+2% +$74.3M 0.43% 34
2023
Q2 		$3.63B Sell
6,978,869
-6,715
-0.1% -$3.62M 0.43% 37
2023
Q1 		$4.02B Buy
6,985,584
+106,233
+2% +$59.9M 0.52% 28
2022
Q4 		$3.78B Buy
6,879,351
+123,256
+2% +$65.3M 0.53% 27
2022
Q3 		$3.42B Buy
6,756,095
+115,628
+2% +$64.7M 0.52% 27
2022
Q2 		$3.6B Buy
6,640,467
+99,048
+2% +$54.5M 0.53% 28
2022
Q1 		$3.85B Buy
6,541,419
+137,614
+2% +$79.1M 0.48% 30
2021
Q4 		$4.26B Buy
6,403,805
+214,375
+3% +$134M 0.51% 26
2021
Q3 		$3.53B Buy
6,189,430
+119,371
+2% +$65.5M 0.47% 30
2021
Q2 		$3.05B Buy
6,070,059
+173,240
+3% +$81.7M 0.42% 41
2021
Q1 		$2.68B Buy
5,896,819
+93,794
+2% +$44.8M 0.41% 40
2020
Q4 		$2.7B Buy
5,803,025
+193,906
+3% +$90.9M 0.45% 36
2020
Q3 		$2.47B Buy
5,609,119
+73,434
+1% +$30.3M 0.48% 35
2020
Q2 		$2B Buy
5,535,685
+76,104
+1% +$25.5M 0.43% 40
2020
Q1 		$1.54B Sell
5,459,581
-81,340
-1% -$25.6M 0.4% 48
2019
Q4 		$1.8B Buy
5,540,921
+151,622
+3% +$46M 0.38% 47
2019
Q3 		$1.57B Buy
5,389,299
+89,130
+2% +$25.5M 0.37% 51
2019
Q2 		$1.55B Buy
5,300,169
+10,130
+0.2% +$2.79M 0.38% 49
2019
Q1 		$1.45B Buy
5,290,039
+392,325
+8% +$97.6M 0.37% 54
2018
Q4 		$1.09B Buy
4,897,714
+422,625
+9% +$99.2M 0.34% 56
2018
Q3 		$1.09B Buy
4,475,089
+126,552
+3% +$29.1M 0.31% 63
2018
Q2 		$899M Buy
4,348,537
+219,072
+5% +$46.5M 0.28% 66
2018
Q1 		$850M Buy
4,129,465
+212,244
+5% +$44.5M 0.28% 66
2017
Q4 		$742M Buy
3,917,221
+158,961
+4% +$30.5M 0.25% 76
2017
Q3 		$710M Buy
3,758,260
+157,011
+4% +$28.4M 0.26% 75
2017
Q2 		$627M Buy
3,601,249
+38,806
+1% +$6.52M 0.25% 79
2017
Q1 		$546M Buy
3,562,443
+232,624
+7% +$35.6M 0.22% 87
2016
Q4 		$469M Buy
3,329,819
+134,030
+4% +$19.8M 0.22% 90
2016
Q3 		$507M Buy
3,195,789
+140,777
+5% +$21.7M 0.26% 73
2016
Q2 		$451M Sell
3,055,012
-65,296
-2% -$9.64M 0.25% 80
2016
Q1 		$441K Buy
3,120,308
+40,214
+1% +$5.39M 0.23% 83
2015
Q4 		$436M Buy
3,080,094
+10,952
+0.4% +$1.46M 0.25% 77
2015
Q3 		$375M Buy
3,069,142
+26,537
+0.9% +$3.46M 0.23% 86
2015
Q2 		$394M Buy
3,042,605
+22,784
+0.8% +$2.97M 0.22% 90
2015
Q1 		$405M Buy
3,019,821
+78,900
+3% +$10.2M 0.23% 90
2014
Q4 		$368M Buy
2,940,921
+117,735
+4% +$14.3M 0.22% 94
2014
Q3 		$343M Sell
2,823,186
-24,048
-0.8% -$2.92M 0.22% 92
2014
Q2 		$336M Sell
2,847,234
-73,065
-3% -$8.6M 0.22% 95
2014
Q1 		$351M Buy
2,920,299
+307,116
+12% +$36.5M 0.24% 86
2013
Q4 		$291M Buy
2,613,183
+135,857
+5% +$13.5M 0.2% 101
2013
Q3 		$228M Buy
2,477,326
+101,896
+4% +$9.21M 0.18% 113
2013
Q2 		$201M Buy
+2,375,430
New +$198M 0.18% 117

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management's TMO Position: Q1 2026 in Review

Geode Capital Management increased its Thermo Fisher Scientific (TMO) stake by 2.6% in Q1 2026, buying an estimated $115M and bringing the position to 8,407,891 shares worth $4.11B. The position accounts for 0.26% of the portfolio, ranked #59.

Geode Capital Management first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $4.73B in Q4 2025. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Geode Capital Management held 8,407,891 shares of Thermo Fisher Scientific worth $4.11B as of Q1 2026.
  • Geode Capital Management bought 211,414 Thermo Fisher Scientific shares in Q1 2026, an estimated $115M.
  • Thermo Fisher Scientific made up 0.26% of Geode Capital Management's portfolio in Q1 2026, its #59 holding.
  • Geode Capital Management first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
  • Geode Capital Management's Thermo Fisher Scientific position peaked at $4.73B in Q4 2025.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.